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Background: Despite their potential as low-threshold, low-cost and high-flexibility treatments of depression,
behavioural activation and physical exercise have not yet been directly compared. This study will examine the
effects of these interventions, administered via the Internet. The added effect of providing a treatment rationale will
also be studied, as well as a relapse prevention program featuring cognitive behavioural therapy components.
Methods/Design: This randomised controlled trial will include 500 participants meeting the diagnostic criteria for
major depression, recruited in multiple cycles and randomised to either a waiting list control group with delayed
treatment, or one of the four treatment groups: (1) physical exercise without a clear treatment rationale; (2) physical
exercise with treatment rationale; (3) behavioural activation with treatment rationale; or (4) behavioural activation
without a clear treatment rationale. Post treatment, half of the participants will be offered a relapse prevention
program. Primary outcome measure will be the Patient Health Questionnaire 9-item. Secondary measures include
diagnostic criteria for depression, as well as self-reported anxiety, physical activity and quality of life. Measurements -
done via telephone and the Internet - will be collected pre-treatment, weekly during treatment period, immediately
post treatment and then monthly during a 24-month follow-up period.
Discussion: The results of this study will constitute an important contribution to the body of knowledge of the
respective interventions. Limitations are discussed.
Trial registration: ClinicalTrials.gov: NCT01619930
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It is well recognised in clinical and research settings that
patients with depression account for a large portion of
those seeking healthcare. In a large study of the 12-
month and lifetime prevalence of mental disorders
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reproduction in any medium, provided the orfound to be the single most common disorder with a
lifetime prevalence of 12.8% and a 12-month equivalence
of 3.9% [1]. In the year 2020 it is expected that depres-
sion will be the world-wide second largest disease-
related cause of disability, second only to heart disease
[2]. In addition to the personal suffering involved, de-
pression is a major source of economic strain for society.
The total annual cost of depression in Europe in 2004
has been estimated to €118 billion, corresponding to 1%
of the total European economy at the time [3].al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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(antidepressants) and psychological (psychotherapy), with
research showing near-equal efficacy between them [4].
Unfortunately, research also indicates that far from all
who suffer from depression seek treatment [5]. A wider
treatment arsenal including low-cost, high-flexibility treat-
ments is therefore desirable. One promising treatment is
activation, two kinds of which are behavioural activation,
and one solely focused on physical exercise. These two
kinds of activation therapy have the potential to be admi-
nistered via the Internet, which would both lower the
threshold for those seeking treatment, while also provi-
ding effective treatment to a low cost. In this therapeutic
context, physical exercise can be considered a focused
form of behavioural activation [6] in the respect that both
interventions require the client to schedule and perform
activities. A recent innovative randomised controlled trial
comparing aerobic exercise to low-intensity stretching -
both treatment arms having equal levels of activity fre-
quency and social interaction - found no between-group
difference in antidepressant effect [7]. An explanation for
this result could be that it was the common activation
component that caused the antidepressant effect, rather
than the physical exercise per se. At present it is unknown
whether any antidepressant effects of behavioural activa-
tion and physical exercise are treatment-specific or due to
the common activation factor. Using an advanced trial de-
sign, the study herein described will be able to evaluate
the antidepressant effects of both the respective treat-
ments in themselves, and compare the two.
Strategies now known as behavioural activation (BA),
originally developed by Lewinsohn and colleges in the
1970s, focused on pleasant events scheduling and BA is
now defined as a structured, brief psychotherapeutic
method to: (1) increase engagements in adaptive (appeti-
tive) activities; (2) decrease engagements in activities
that maintain or increase depression; and (3) increase
access to reward [8]. A 2007 meta-analysis found BA to
have a large effect on depressive symptoms, with the
added benefit of being relatively uncomplicated, time-
efficient and not requiring complex skills of patient or
therapist [9]. Explaining the BA treatment rationale to
patients is widely considered an early step in treatment
[6], yet the component-specific effect of providing this
rational has not yet been the subject of research.
Acknowledging the well-known effect on outcome in
cognitive behavioural therapy of the client’s acceptance
of treatment rationale [10], this study will be able to dis-
tinguish the effect of providing a clear and extensive
treatment rationale in BA therapy. This study will also
be the first to test whether BA therapy can be adequately
administered via the Internet (see [6,11]).
A 2007 Cochrane review found physical exercise to
have a large clinical effect on depression. If however themethodologically weak studies were excluded, the clin-
ical effect was moderate and non-significant [12]. Ac-
knowledging the methodological weaknesses of previous
studies, a more recent meta-analysis including only
randomised controlled trials suggests a large and signifi-
cant effect of physical exercise on depression [13]. It
should be noted that the causality of physical exercise as
treatment of depression has been questioned. In a large
population-based study, De Moor et al. [14] found that
in genetically identical twins, the twin who exercised
more did not display fewer symptoms of depression,
suggesting that the causal role should be ascribed to a
common genetic factor rather than the exercise itself.
Indeed, the specific mechanism by which physical exer-
cise has an effect on depression, if any, is still unknown.
As is the case with BA therapy, no previous research has
studied the unique, component-specific effect of provid-
ing a clear treatment rationale. Providing this rationale
may increase the patient’s motivation to exercise, which
in itself may give a direct placebo-type antidepressant
effect and/or indirectly reduced depressive symptoms
following increased physical activity (which can be mea-
sured). This trial will be the first to study the component-
specific effect of providing a clear treatment rationale in
physical exercise therapy for depression.
In addition to studying the effects of Internet-
administered physical exercise and BA - with and without
providing a clear treatment rationale - and comparing
them, this trial will include a depression relapse preven-
tion program featuring cognitive behavioural therapy
(CBT) components. Within 15 years, depression relapses
may occur in as much as 90% of those experiencing an
acute depression episode [15]. Psychotherapeutic inter-
ventions have been shown to effectively reduce the risk of
depression relapses [16], yet no previous study has exam-
ined whether this type of intervention can be administered
via the Internet (see [11]). With there being ample
evidence for the effects of Internet-based CBT on depres-
sion [17], a CBT-style relapse prevention program deliv-
ered via the Internet holds great potential. This trial will
feature such a program, provided after the physical exer-
cise or BA intervention.
Methods/Design
Design
This randomised controlled trial has been registered in
clinicaltrials.gov (NCT01619930). It will feature four
treatment groups and a waiting list control group with
delayed treatment: (1) physical exercise without treat-
ment rationale; (2) physical exercise with treatment
rationale; (3) BA with treatment rationale; (4) BA with-
out treatment rationale; and (5) a waiting list control
group, the participants of which will be randomised
evenly to the four treatment groups after a 12-week
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an estimated period of 1 year, with the participants of
every cycle being evenly distributed to the five groups.
Even distribution of participants to the different cycles
will be pursued. After the treatment period of 12 weeks,
50% of each of the four treatment groups will receive a
relapse prevention program. All participants will be
monitored for 24 months post treatment (Figure 1).
Screening and participants
Participants will be recruited nation-wide by means of
advertisements in press and on the Internet. Application
is done online, where prospective participants will also
find further information on the study as well as the
questionnaires serving as screening instruments. Before
final inclusion, participants are required to provide writ-
ten, informed consent.
The study population will consist of adults with diag-
nosed major depression according to DSM-IV-TR [18]
criteria, with depression being the primary diagnosis. A
score of 15 to 35 on the self-rated version of the
Montgomery-Åsberg Depression Rating Scale (MADRS-
S) [19] is also required. Other inclusion criteria include:
living in Sweden and being able to read Swedish; being at
least 18 years old; and having access to a computer with
an Internet connection. Use of psychoactive medication is
not grounds for non-inclusion if the dosage has been
stable for the past 3 months and will continue to be stable
during the intervention period. Any changes in medica-
tion during the study period will be noted along with the
other measurements at treatment completion and at the
12- and 24-month follow-ups. If the proportion of patientsScreen
500 participants are rando
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Figure 1 Flow diagram of the trial. PE, physical exercise; BA, behaviouralwho use pharmacotherapy differs between the treatment
groups we will use pharmacotherapy metrics as factors in
the mixed model analysis to adjust for a possible confoun-
der effect when treatment effects are studied. Individuals
meeting diagnostic criteria for treatment-demanding
additional psychiatric conditions (for example, schizophre-
nia and bipolarity) will be excluded and referred to health-
care services. Individuals deemed suicidal or too severely
depressed will also be excluded, the latter indicated by the
scoring of item 9 on MADRS-S concerning the risk of
suicide. When in doubt, a telephone interview will be con-
ducted. Individuals currently receiving other psychological
treatment will be excluded.
Initial selection of participants will be based on the
results of the online screening instruments, consisting of
MADRS-S, PHQ-9 [20], IPAQ [21], QOLI [22], GAD-7
[23] (see below) and a number of additional questions
on demographics and previous treatment experiences.
While the other instruments return as outcome mea-
sures (see below), MADRS-S will only be used in the
screening procedure as a measure of the severity of
depression symptoms. Previous research has shown that
MADRS-S has a good internal consistency (Cronbach’s
alpha 0.85 to 0.94), a satisfactory singe-component factor
structure (47% to 69% variability explanation power),
and a good correlation (Pearson’s correlation 0.81 to
0.91) with the clinician-rated version [24]. The psycho-
metric properties of the Internet-administered version of
MADRS-S has found to be sufficiently similar to the pen
and paper version [25,26].
Prospective participants meeting initial inclusion cri-
teria will be interviewed via telephone according to theing
mised to the 5 groups
Recruitment in 
several waveses 















n = 50 + 12 in 
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llow-up
a total of 8 telephone interviews
up period
activation; RP, relapse prevention program.
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[27] manual. Diagnostic interviews conducted per tele-
phone have previously been found to be in very good
agreement with face-to-face interviews regarding major
depressive disorder [28]. The screening interviews will
be conducted by supervised, clinical psychology master’s
students, trained in the use of MINI. The interviewers
will meet together with experienced clinical psycholo-
gists and psychiatrists to discuss final inclusion and to
tailor the respective treatment program to each partici-
pant. Randomisation of participants to the different
groups will be done by a statistician not otherwise
involved in the study, using a computer-generated list
with variables not known to the principle researchers.
Participants who drop out will not be replaced.
Participants will access treatment programs, register
data and communicate with their therapists using an
SSL-encrypted online interface. Participants will log in
using their anonymous participant number, a chosen
password and unique, single-use codes sent by SMS or
ordinary mail.
The study aims to detect a moderate difference in the
primary outcome measure (see section 2.4.3 below) with
80% power and a 5% significance level (Bonferroni-
adjusted). In accordance with this, the study will feature
500 participants, with 100 in each treatment group (125
after the control group is dissolved and divided) and a
total of 250 (half of each of the four treatment groups)
receiving relapse prevention.
Interventions
All interventions will be administered and monitored via
the online interface. Both the BA and physical exercise
groups will receive therapist support, provided by the
above-mentioned clinical psychology master’s students,
supervised by an experienced clinical psychologist.
Physical exercise
Based on the screening data, an individualised exercise
program, specifying intensity, frequency and duration of
physical activity, will be provided for each participant in
treatment groups 1 and 2, just prior to the treatment
period commencing. A user-friendly pulse-watch, and/or
pedometer will also be provided. Participants register
their physical activity and receive automated, individua-
lised feedback. The physical exercise intervention will
run for 12 weeks, divided into 12 weekly modules.
Behavioural activation (BA)
The BA intervention provided to groups 3 and 4 will
feature a variety of behaviour change strategies, includ-
ing mapping of current behaviour, finding reinforcing ac-
tivities and creating a difficulty-ranked hierarchy of
these activities, activity scheduling and structuring, self-monitoring of mood and activity, and so on. Each par-
ticipant will receive approximately 15 min of therapist
support per week. The BA intervention will run for 12
weeks, divided into 12 weekly modules.BA treatment rationale
The treatment rationale provided to treatment group 3
will be similar to that used in a popular self-help book
[29] for treatment of depression. According to this ra-
tionale, individuals suffering from depression are trapped
in a Trigger-Response-Avoidance-Pattern: a vicious cir-
cle of avoidance leading to less and less reinforcing stim-
uli. In accordance with this, BA serves to break the
vicious circle and thereby relieve the individual of de-
pressive suffering. Treatment group 4, which will not be
provided with the TRAP rationale, will instead be
informed that previous research indicates that activation
improves wellbeing. Group 4 will receive the same
amount of therapist support as group 3.Physical exercise treatment rationale
Both groups 1 and 2 will be informed that physical exer-
cise has been shown to decrease depression and especially
fatigue, one of the core symptoms of depression. In
addition to this, group 2 will also be provided with a fuller
treatment rationale, according to which depression should
be seen in the context of a vicious circle of lessened activ-
ity and energy levels. Both groups will receive the same
amount of therapist support.Control group
The waiting list control group will perform weekly mea-
surements and receive automated, individualised feedback
in graphic and message form comparing the recent results
with those from previous weeks. After a 12-week delay,
the group members will be randomised to one of the four
treatment groups and receive treatment accordingly.Relapse prevention
After the 12 treatment weeks and immediate post-
treatment measurements, 50% of each treatment group of
each recruitment cycle will be offered a relapse prevention
program. The program will be based on and be similar to
that used in a previous study [30] on relapse prevention
for people suffering residual depressive symptoms after
having previously received either psychotherapy or anti-
depressant medication. The Internet-administered, therap-
ist-assisted, progressive module-based program featured
many of the standard components of cognitive behav-
ioural therapy, including psychoeducation, BA, goal for-
mation and mindfulness exercises.
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All questionnaires will be administered via the Internet
except for the clinical interviews, which will be con-
ducted via telephone. Both these administration formats
are considered valid methods of acquiring data [28,31].Demographic and attitude data
At screening, data on sex, age, marital status, educa-
tional level, and so on will be collected to allow analysis
of factors influencing treatment outcome and willingness
to seek treatment. For the same purpose, ratings of the
participants’ views on treatment credibility and expected
results will also be recorded at screening using the five-
item Treatment Credibility Scale (TCS) [32]. Participants
will be administered the TCS for both the BA interven-
tion and the physical exercise intervention, separately,
after having read a brief description of the two interven-
tions. Based on the parity of their participant ID number,
the participants will then be randomised to either an-
swer the TCS about BA first and then the same five
questions about physical exercise, or vice versa. Partici-
pants will also answer what intervention they would pre-
fer and to what degree.Diagnosis
Initial diagnosis of depression, according to DSM-IV cri-
teria, will be made using part A of the structured Mini-
International Neuropsychiatric Interview (MINI) [27].
Additionally, each follow-up month, 33% of each treat-
ment group will be interviewed per telephone. Hence,
on an individual level, interviews will be conducted
every third month during the follow-up period of 24
months (namely, eight follow-up interviews in total for
each participant). On a group level, interviews will be
conducted every month. The built-in data-loss of 66% each
month will however be data missing completely at random
since the participants are randomised to their respective
months, making the procedure unbiased (see [33]).Primary outcome
PHQ-9 [20] is the depression module of the Patient Health
Questionnaire (PHQ), designed to score each of the nine
DSM-IV criteria for depression as ‘0 (not at all)’ to ‘3
(nearly every day)’, allowing it to be used as both a diag-
nostic instrument and symptom severity scale. PHQ-9 has
been shown to have good internal consistency (Cronbach’s
alpha 0.86 to 0.89), good diagnostic validity [34,35] and
adequate sensitivity to be used as an outcome mea-
sure [36,37]. Participants will complete the PHQ-9
weekly during the treatment period, immediately upon
completion of treatment and then monthly during follow-
up (24 months).Secondary outcomes
In addition, three secondary outcome measures will be
used. The International Physical Activity Questionnaire
(IPAQ) [21] was designed to be a cross-nationally valid
self-reported measure of physical activity, and features
questions on the amount of time (minutes, hours and
days) spent in the last 7 days on physical activity and
sitting still. IPAQ will be administered upon treatment
completion and thereafter at the 12- and 24-month
follow-ups.
The seven-item general anxiety scale, GAD-7 is used
for assessing anxiety and screening for generalised anx-
iety disorder, with psychometric evaluation having
yielded good internal consistency (Cronbach’s alpha
0.92) and a good factorial structure (69% to 81% of vari-
ance explained) [23]. GAD-7 will be administered upon
treatment completion and thereafter monthly during the
follow-up period.
The Quality Of Life Inventory (QOLI) [22] will also be
included. QOLI features 32 items ranging over 16 areas
of life (health, economy, work, and so on) and has good
internal consistency (Cronbach’s alpha 0.77 to 0.89) and
test-retest reliability (0.80 to 0.91) [22]. QOLI will be
administered upon treatment completion and thereafter
at the 12- and 24-month follow-ups.
At screening, as well as immediate after treatment and
at the 12- and 24-month follow-ups, participants will
also answer the EQ-5D [38] to assess generic health sta-
tus, and the Trimbos/iMTA questionnaire for Costs
associated with Psychiatric illness (TiC-P) [39] to assess
health economic aspects.
Analysis
The study design will allow for multiple comparisons:
the two physical exercise groups (separately and to-
gether) will be compared to controls, as will the two BA
groups (separately and together). In all other analyses,
the groups in question will include those from the con-
trol group later randomised to interventions, this to in-
crease the statistical power. The two physical exercise
groups will be contrasted with the two BA groups.
Further, the physical exercise group with treatment
rationale (group 1) will be contrasted with the group
without (group 2), and the BA group with treatment ra-
tionale (group 3) will be contrasted with the BA group
without (group 4). Finally, the four groups receiving re-
lapse prevention will be contrasted with the four groups
that do not. At the 12- and 24-month follow-ups, within-
group comparisons will be made with previous results.
A number of statistical analyses will be deployed.
Treatment outcomes will be examined using mixed
effect models, Bonferroni-correcting for multiple com-
parisons. This method is deemed preferable to uni- and
multivariate repeated measures of variance [40],
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Kaplan-Meier estimator will be used to estimate survival
rates during the study period. To find potential predictors
of treatment outcomes (including treatment adherence
and drop-out), logistic regression analysis on background
variables will be performed (see [41]).
Since all questionnaire data will be supplied directly by
the participants through the online interface, there is no
risk of data loss or data distortion along the way. Data
will be stored encrypted and in unidentifiable form
(using participant-numbers). Standard missing data ana-
lysis will determine if unexpected missing data due to
participant drop-out are random or not.
Ethics
This study has been approved by the regional Ethical
Board. As in any trial, there are a number of ethical con-
cerns, all of which will be adequately addressed. First
and foremost, great care will be taken not to include
participants too severely depressed or suffering from
other disorders better treated elsewhere. Should suspi-
cion arise during the intervention period that an enrolled
participant is experiencing a significant decline in health
due to the intervention, the supervising clinicians (licensed
psychologists, psychotherapists or psychiatrist) may opt to
end the participation prematurely and direct the partici-
pant to other healthcare services. No adverse side effects
of BA or physical exercise are expected, yet side effects
will nonetheless be investigated by asking standard treat-
ment side effects questions at the post-treatment measure-
ments, in accordance with the recommendations by
Linden [42]. As in all internet interventions, the privacy of
the participants is of paramount importance [43]. In this
trial, participants will use anonymous participant codes to
interact with a secure online interface after a two-stage
log-in procedure.
Discussion
This protocol describes a large (n = 500) randomised
controlled trial examining the effects on depression of
internet-administered behavioural activation and phys-
ical exercise programs, with relapse prevention and
treatment rationale as additional distinguishable compo-
nents. As the economic strain and personal suffering asso-
ciated with depression continues to increase, so does the
need for a variety of treatment methods. Despite their
potentials as low-threshold, low-cost, high-flexibility treat-
ments of depression, behavioural activation and physical
exercise have yet to be the subject of much research. Any
future integration of behavioural activation and physical
exercise into healthcare systems will of course require sci-
entific evidence of the effects of these treatments. The
study herein described will make substantial contributions
to the body of knowledge on these areas, while alsoexamining the separate effects of providing a clear treat-
ment rationale. The potential of a CBT-style program to
prevent depression relapse will also be examined. The ran-
domised controlled design is stringent throughout the
study, allowing valid conclusions on the effects of the
respective interventions. To our best knowledge, this
study is also the first to feature Internet-administered be-
havioural activation; the results will consequently provide
a first indication whether the treatment can be adequately
translated to this promising administration format.
This study has some limitations that need to be recog-
nised. For ethical reasons, individuals suffering from too
severe depression, with or without the risk of suicide,
will not be included. Since the participants in the waiting
list control group will receive treatment after a 12-week
delay, this study will lack a control group in the follow-
up period. This again is for ethical reasons. As in almost
all studies featuring psychotherapeutic interventions,
blinding participants and researchers is not feasible. A
final aspect in need of recognition is the involvement of
the master’s students in clinical psychology. To compen-
sate for the students’ lack of training and experience, an
experienced licensed clinical psychologist and psycho-
therapist will supervise all involvement.
Trial status
Recruitment is scheduled to begin in January 2013. The
participants of the first recruitment cycle are planned to
commence treatment later that spring.
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